0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.14%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
0.61%
Positive EBIT growth while 0335.HK is negative. John Neff might see a substantial edge in operational management.
0.61%
Positive operating income growth while 0335.HK is negative. John Neff might view this as a competitive edge in operations.
27.53%
Net income growth under 50% of 0335.HK's 247.19%. Michael Burry would suspect the firm is falling well behind a key competitor.
-44.39%
Negative EPS growth while 0335.HK is at 248.53%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
3.34%
Diluted EPS growth under 50% of 0335.HK's 248.53%. Michael Burry would worry about an eroding competitive position or excessive dilution.
129.62%
Slight or no buybacks while 0335.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
23.43%
Diluted share change of 23.43% while 0335.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
114.48%
Positive OCF growth while 0335.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
79.98%
Positive FCF growth while 0335.HK is negative. John Neff would see a strong competitive edge in net cash generation.
31.83%
Positive 10Y revenue/share CAGR while 0335.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-55.08%
Negative 5Y CAGR while 0335.HK stands at 1.25%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-50.53%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
305.97%
Positive long-term OCF/share growth while 0335.HK is negative. John Neff would see a structural advantage in sustained cash generation.
-9.31%
Negative 5Y OCF/share CAGR while 0335.HK is at 50.73%. Joel Greenblatt would question the firm’s operational model or cost structure.
-66.91%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-34.65%
Negative 10Y net income/share CAGR while 0335.HK is at 55.70%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.96%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
110.85%
Positive short-term CAGR while 0335.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-3.30%
Negative 5Y equity/share growth while 0335.HK is at 85.61%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-32.09%
Negative 3Y equity/share growth while 0335.HK is at 44.29%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-55.41%
Firm’s AR is declining while 0335.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
83.57%
Inventory shrinking or stable vs. 0335.HK's 14333.33%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-17.48%
Negative asset growth while 0335.HK invests at 4.07%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-51.38%
We have a declining book value while 0335.HK shows 5.43%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.12%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-18.82%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-17.25%
We cut SG&A while 0335.HK invests at 6.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.